135.02 -0.19 (-0.14%)
NVO
| Trade NVO now with |
|
Stock Details
Last Trade:135.02 Change:-0.19 (-0.14%) Prev Close:135.21 Open: 133.15 Days Range:133.15 – 135.22 52 Week Range: 94.58 - 135.68 Volume:239060 P/E: N/AEPS:0.00
View AllRecent Alerts 02/09/12
Recent Alert on 11/17/11 at 3:59pm
Disappointing Trial Results on Albiglutide Make Glaxo Bid for Human Genome Less Likely -RBC (GSK) (HGSI)
Disappointing Trial Results on Albiglutide Make Glaxo Bid for Human Genome Less Likely -RBC (GSK) (HGSI)
Traders sold shares of Human Genome Sciences (Nasdaq: HGSI) Thursday following a late-stage study which showed GlaxoSmithKline's (NYSE: GSK) experimental albiglutide disappointed compared to Novo Nordisk's (NYSE: NVO) Victoza. Diabetes patients... Read More
Recent Alert on 11/17/11 at 3:59pm
Disappointing Trial Results on Albiglutide Make Glaxo Bid for Human Genome Less Likely -RBC (GSK) (HGSI)
Disappointing Trial Results on Albiglutide Make Glaxo Bid for Human Genome Less Likely -RBC (GSK) (HGSI)
View AllRecent Press Releases
Press Release on 02/09/12 at 8:31am
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 8 February 2012
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons on 8 February 2012
Press Release on 02/06/12 at 6:22am
Novo Nordisk A/S : Trading in Novo Nordisk shares by board members, executives and associated persons on 3 February 2012
Novo Nordisk A/S : Trading in Novo Nordisk shares by board members, executives and associated persons on 3 February 2012
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 02/05/12 at 11:28pm
Put Options: Inferring Investment Ideas From A Self-Made Billionaire
Put Options: Inferring Investment Ideas From A Self-Made Billionaire